Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial
- Journal:
- The Lancet
- Published:
- Affiliations:
- 9
- Authors:
- 17
| Institutions | Authors | Share |
|---|---|---|
| Meiji Holdings Co., Ltd., Japan | 0.53 | |
| Sapporo Medical University, Japan | 0.12 | |
| Toho University, Japan | 0.06 | |
| Nagasaki University Hospital, Japan | 0.06 | |
| Huashan Hospital, Fudan University, China | 0.06 | |
| Keio University, Japan | 0.06 | |
| Aichi Medical University Hospital, Japan | 0.06 | |
| Fujita Health University, Japan | 0.03 | |
| University of Pittsburgh (Pitt), United States of America (USA) | 0.03 |